Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Adult Stem Cells & Exosome-based Therapeutics 2021

Adult Stem Cells & Exosome-based Therapeutics 2021

Date: Wednesday, 17 November 2021 - Thursday, 18 November 2021
Location: Tokyo, Japan

Keynote Speakers

Sai Kiang Lim

Sai Kiang Lim
Research Director, Institute of Medical Biology, A*STAR

Niek Dekker

Niek Dekker
Principal Scientist, Discovery Sciences, AstraZeneca

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Chulhee Choi

Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated

Yong Song Gho

Yong Song Gho
Professor, Pohang University of Science And Technology (POSTECH)


SelectBIO Adult Stem Cells & Exosome/EV-based Therapeutics Asia 2021 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas:
  • Extracellular Vesicles Produced by Adult Stem Cells and their Functional Activities
  • Exosome/EV Engineering
  • Exosomes/EV-based Therapeutics Development and Regenerative Medicine
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas:
  • Technologies for Isolation and Characterization as Well as High-Volume Production of EVs for Potential Therapeutics Applications
  • Exosomes/EVs Derived from Adult Stem Cells and Their Theraeputic/Regenerative Properties
  • Role in Cancer and Various Disease Classes -- Regenerative Medicine
  • Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
  • Regulatory Landscape in the Use of Exosomes/EVs for Therapeutics
The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date based on research involving stem cells and stem cell-derived extracellular vesicles (EVs) for clinical utility and regenerative medicine.

All Delegates and Exhibitors Receive Full Access to the Co-Located Conference Track: Cell & Gene Therapy and Cancer Immunotherapy Asia 2021.

Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event.  Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.

Agenda Topics

  • Engineering Exosomes and Extracellular Vesicles (EVs)
    • Engineering EVs as Biologic Drugs
  • Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy and Intersection with the Extracellular Vesicles (EV) Axis
  • Stem Cell-based EVs for Regenerative Medicine

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2021-11-17 00:00:002021-11-18 00:00:00Europe/LondonAdult Stem Cells and Exosome-based Therapeutics 2021Adult Stem Cells and Exosome-based Therapeutics 2021 in Tokyo, JapanTokyo,